Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Kezar Life Sciences, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 83 | 75 | −8 |
| Shares | 26.6M | 27.6M | +1.04M (+3.9%) |
| Value | $158.0M | $150.1M | −$7.88M (−5.0%) |
New holders (5)
Institutions that held Kezar Life Sciences, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| OrbiMed Advisors LLC | 557,191 | $3.03M | 0.03% |
| Healthcare of Ontario Pension Plan Trust Fund | 84,400 | $458.0K | 0.00% |
| Dimensional Fund Advisors LP | 33,788 | $183.0K | 0.00% |
| Trexquant Investment LP | 14,185 | $77.0K | 0.01% |
| State of Wyoming | 1,762 | $10.0K | 0.01% |
Sold out (13)
Institutions that held Kezar Life Sciences, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Avidity Partners Management LP | 1,907,081 | $11.4M |
| FMR LLC | 1,346,739 | $8.03M |
| Candriam Luxembourg S.C.A. | 584,956 | $2.93M |
| Virtus ETF Advisers LLC | 54,313 | $324.0K |
| Susquehanna International Group, LLP | 30,401 | $181.0K |
| Manufacturers Life Insurance Company, The | 21,139 | $126.0K |
| Integral Health Asset Management, LLC | 20,000 | $119.0K |
| ExodusPoint Capital Management, LP | 17,668 | $105.0K |
| RBF Capital, LLC | 12,150 | $72.0K |
| Bank of Montreal | 10,772 | $67.0K |
| Simplex Trading, LLC | 411 | $2.00K |
| Group One Trading, L.P. | 200 | $1.00K |
| Meridian Wealth Partners, LLC | 233 | $1.00K |